1. Clinical Overview
A fixed-dose combination topical preparation containing a super-potent synthetic corticosteroid (Clobetasol propionate) and the active hormonal form of Vitamin D (Calcitriol). This combination is designed for the topical treatment of chronic, stable plaque psoriasis. Clobetasol provides rapid anti-inflammatory, immunosuppressive, and antiproliferative effects, while Calcitriol modulates keratinocyte differentiation and proliferation, offering a synergistic and potentially steroid-sparing effect for better long-term management with reduced risk of steroid-induced atrophy.
| Onset | Duration | Bioavailability |
|---|---|---|
| Therapeutic effects (reduction in scaling, erythema, and plaque thickness) are typically observed within 1-2 weeks of treatment initiation. | Effects are sustained during treatment. Rebound or relapse can occur after discontinuation, necessitating maintenance therapy or alternative management. | Topical bioavailability is low but variable, estimated at 1-5% for clobetasol and <1% for calcitriol, depending on skin condition, application site, and use of occlusion. |
2. Mechanism of Action
The combination exerts a synergistic effect on psoriatic plaques. Clobetasol propionate binds to glucocorticoid receptors, leading to the synthesis of anti-inflammatory proteins (lipocortins) and inhibition of pro-inflammatory mediators (cytokines, leukotrienes, prostaglandins). It causes vasoconstriction, reduces leukocyte migration, and inhibits keratinocyte hyperproliferation. Calcitriol binds to the nuclear Vitamin D Receptor (VDR) in keratinocytes and immune cells, modulating gene expression to promote normal keratinocyte differentiation, inhibit proliferation, and exert immunomodulatory effects by suppressing T-cell activation and cytokine production.
3. Indications & Uses
- Chronic, stable plaque psoriasis (vulgaris) in adults
- Localized, moderate to severe plaque psoriasis
4. Dosage & Administration
Adult Dosage: Apply a thin layer once or twice daily to the affected areas only. The total weekly dose should not exceed 60 grams. Treatment duration should be limited, typically 2-4 weeks. A 4-week treatment-free period is recommended before initiating another course.
Administration: Wash and dry the affected area gently. Apply a thin film and rub in lightly until absorbed. Do not bandage or occlude unless specifically directed by a physician. Wash hands thoroughly after application unless hands are the treatment area. Avoid contact with eyes, mouth, and mucous membranes.
5. Side Effects
Common side effects may include:
- Local burning or stinging sensation
- Skin irritation, itching
- Skin dryness
- Erythema
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Corticosteroids | Increased risk of skin atrophy and systemic steroid effects. | Major |
| Oral Calcium Supplements or Vitamin D analogues (e.g., Calcitriol capsules) | Increased risk of hypercalcemia and hypercalciuria. | Major |
| Thiazide Diuretics (e.g., Hydrochlorothiazide) | May potentiate hypercalcemic effect of calcitriol. | Moderate |
| Systemic Corticosteroids (e.g., Prednisolone) | Additive risk of adrenal suppression and Cushingoid symptoms. | Major |
| CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin) | May increase systemic levels of clobetasol, increasing steroid side effects. | Moderate |
7. Patient Counselling
- DO use only as directed by your doctor, for the prescribed duration and area.
- DO apply a thin layer only.
- DO wash hands before and after application (unless hands are being treated).
- DO report any signs of infection (increased redness, pus, pain) or lack of improvement.
- DON'T use on the face, underarms, or groin unless specifically advised.
- DON'T bandage, wrap, or cover the treated area with tight clothing unless instructed.
- DON'T use for longer than 4 weeks continuously without medical review.
- DON'T share this medication with others.
8. Toxicology & Storage
Overdose: Topical overdose manifests as severe local skin reactions (atrophy, striae, telangiectasia) and signs of systemic corticosteroid and vitamin D toxicity: weakness, fatigue, hypertension, hyperglycemia, polyuria, polydipsia (due to hypercalcemia), nausea, vomiting, constipation, renal calculi, and in severe cases, cardiac arrhythmias.
Storage: Store at room temperature (15-25°C). Protect from light and moisture. Do not freeze. Keep the tube tightly closed. Keep out of reach and sight of children. Do not use after the expiry date printed on the pack.